BiotechTube
Home/CervoMed/Kelly Blackburn, MHA
KB

Kelly Blackburn, MHA

Executive Vice President, Clinical Development

CervoMed

Therapeutic Areas

Neurodegenerative DiseasesNeurology

CervoMed Pipeline

DrugIndicationPhase
NeflamapimodDementia with Lewy Bodies (DLB)Phase 3

Leadership Team at CervoMed

JA
John Alam, MD
Chief Executive Officer
WE
William Elder
Chief Financial Officer and General Counsel
MW
Matthew Winton, Ph.D.
Chief Commercial and Business Officer
JB
Joshua Boger, Ph.D.
Chair Of The Board
OI
Ole Isacson, Dr Med Sci PhD
Chair of Scientific Advisory Board
LC
Lewis Cantley, PhD
Scientific Advisory Board Member
HM
Heidi McBride, PhD
Scientific Advisory Board Member
View full CervoMed profile